In the last trading session, 52.3 million Pfizer Inc. (NYSE:PFE) shares changed hands as the company’s beta touched 0.66. With the company’s per share price at $28.16 changed hands at $0.35 or 1.26% during last session, the market valuation stood at $159.01B. PFE’s last price was a discount, traded about -43.36% off its 52-week high of $40.37. The share price had its 52-week low at $25.20, which suggests the last value was 10.51% up since then. When we look at Pfizer Inc.’s average trading volume, we note the 3-month average coming to 41.78 million.
Pfizer Inc. (NYSE:PFE) trade information
Instantly PFE was in green as seen at the end of in last trading. With action 9.83%, the performance over the past five days has been green. The jump to weekly highs of 28.33 added 1.26% to the stock’s daily price. The company’s shares are showing year-to-date downside of -2.19%, with the 5-day performance at 9.83% in the green. However, in the 30-day time frame, Pfizer Inc. (NYSE:PFE) is 5.63% up.
Pfizer Inc. (PFE) estimates and forecasts
Data shows that the Pfizer Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -7.67% over the past 6 months, a 28.26% in annual growth rate that is considerably higher than the industry average of 5.00%. Year-over-year growth is forecast to reach -4.20% down from the last financial year.
Consensus estimates given by 14 financial analysts project the company’s revenue in the current quarter to hit an average of 12.11B. 13 analysts are of the opinion that Pfizer Inc.’s revenue for the current quarter will be 13.74B. The company’s revenue for the corresponding quarters a year ago was 12.73B and 13.23B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -4.90%. The estimates for the next quarter sales put growth at 3.80%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -27.43%. The 2024 estimates are for Pfizer Inc. earnings to increase by 25.41%, but the outlook for the next 5-year period is at -1.33% per year.
PFE Dividends
Pfizer Inc. is expected to release its next quarterly earnings report in June. The 5.86% annual yield figure for the share gives it an annual dividend of 1.65. It is important to note, however, that the 5.86% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.
